MedPath

Goal Management Training for Methamphetamine Addictio

Not Applicable
Completed
Conditions
Methamphetamine Use Disorder
Mental Health - Addiction
Registration Number
ACTRN12621000172808
Lead Sponsor
Monash University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
36
Inclusion Criteria

(1) aged 18-50; (2) meet Diagnostic and Statistical Manual, Fifth Edition (DSM 5) criteria for methamphetamine use disorder measured with the Mini-International Neuropsychiatric Interview (MINI); (3) seeking and/or engaged in addiction treatment; (4) sufficient English language proficiency to understand the intervention content; (5) able to provide a phone number for follow-up outcomes; (6) intending to stay in the treatment setting for long enough to complete the intervention.

Exclusion Criteria

(1) Individuals who meet DSM-5 criteria for psychosis or schizophrenia; (2) have severe cognitive impairment indicated by a score below 16 in the Montreal Cognitive Assessment (MOCA); or 3) are currently taking benzodiazepines.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in executive function from pre-post interventions, assessed using the overall summary score on the Behavior Rating Inventory of Executive Function- Adult Version (BRIEF-A).[Baseline: One week before the interventions. <br>Post-intervention: Within one week following completion of the interventions.<br>];Feasibility of the program assessed by the proportion of participants who complete GMT+, indicated by an audit of the study database.[Within one week following completion of the interventions];Acceptability of the program compared to the control interventions, assessed by the proportion of people who withdraw consent prior to engaging in GMT+, indicated by an audit of study databases, and participants positive rating of GMT+ on a 4-item acceptability scale.[Within one week following completion of the interventions]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath